UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage and well-being services to individuals age 50 and older addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; Medicaid plans, children's health insurance and health care programs; health and dental benefits; and hospital and clinical services Please visit their website for more information.
*Proprietary Buy Sell Volume Indicator
Revenue: $102.83B |
Revenue Growth (YOY): 12.55% |
Profit (% of Rev): 24.35% |
Income (% of Rev): 5.89% |
Income Growth (YOY): 3.66% |
Operating Income: $8.71B |
Operating Cash Flow: $13.95B |
Operating Cash Flow Growth (YoY): 102.04% |
Annual Dividend Yield: 0.36% |
Total Assets: $299.31B |
Total Liabilities: $194.85B |
Cash & Equivalent: $32.40B |
Total Debt: $74.10B |
Debt/Equity: 0.78 |
Quick Ratio: 0.86 |
Current Ratio: 0.32 |
Price/Book: 5.44 |
Price/Earnings: 22.45 |
EBITDA: $3.92B |
EPS: 6.51 |
Our proprietary analysis employs a weighted average approach integrating both functional and technical parameters, tailored to the sector, industry, and microeconomic factors. This methodology assigns dynamic weights to the parameters, with a focus on recent trends, ensuring a nuanced evaluation for informed investment decisions. Considering all the above parameters, in addition to some of the derived parameters of the stock in conjunction with its sector and macroeconomic conditions, our proprietary Weighted Average AI model gives a rank of Buy.
TheoryofStocks is not registered as an investment advisor with any regulatory authority. The information provided on this Website is for educational purposes only and should not be construed as financial or investment advice. By continuing to use this site, you are agreeing to the Terms of Use and Privacy Policy. Please read our Disclaimer.
Contact @ support@theoryofstocks.com
© 2024 Stock Articles. All rights reserved.